Community Health Systems, Inc. logo

Community Health Systems, Inc.

CYH

NYSEHealthcareMedical - Care Facilities

Previous close

$3.01

+$0.03 · +1.01%

Aug 21, 4:00 PM ET

Pre-market

$3.01

$0.00 · 0.00%

Aug 24, 4:01 AM ET

CYH company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

80

Undervalued

Momentum

52

Neutral

Sentiment

53

Mixed

Risk resilience

40

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Community Health Systems, Inc. (CYH) operates as a major healthcare provider across the United States, focusing on the ownership, leasing, and management of general acute care hospitals. The organization offers a comprehensive array of medical services, including emergency care, general and specialized surgical procedures, critical care, internal medicine, obstetrics, and various diagnostic capabilities. Additionally, they provide psychiatric services, rehabilitation programs, skilled nursing, and in-home care. Beyond its hospital-based offerings, the company delivers outpatient services through a diverse network of facilities. These encompass primary care practices, urgent care centers, independent emergency departments, ambulatory surgery centers, advanced imaging and diagnostic centers, retail health clinics, and direct-to-consumer virtual health consultations. As of December 31, 2021, CYH's holdings included 83 hospitals, either owned or leased. This total comprised 81 general acute care facilities and two specialized stand-alone rehabilitation or psychiatric hospitals, collectively providing a capacity of 13,289 licensed patient beds. The company was established in 1985 and its corporate headquarters are situated in Franklin, Tennessee.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Kevin J. Hammons
Listed since
Jun 9, 2000
Employees
50,500

Market position

Day range

Current $3.01

52-week range

Current $3.01

Open
$3.025
Previous close
$2.98
Volume
463.77K
0.26× average
Average volume
1.78M
Average daily volume
Market cap
424.44M USD
Beta
1.86
Market reference 1
50-day average
$3.127
-3.74% below average
200-day average
$3.1472
-4.36% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
11.74B USD
P/E (TTM)
-1.33×
P/B (TTM)
-0.29×
P/S (TTM)
0.02×
EV / EBITDA
5.81×
Earnings yield
121.75%
Free cash flow yield
49.75%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
58.08%
Operating margin
-38.72%
Net margin
-1.34%
Return on equity
-36.51%
Return on assets
3.85%
Return on invested capital
-83.24%

Financial health

Debt / equity
-7.34×
Current ratio
1.46×
Altman Z-score
2.69
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends54%5%-43%-92%Gross margin, FY2021: 41.11%Gross margin, FY2022: 40.18%Gross margin, FY2023: 40.69%Gross margin, FY2024: 41.71%Gross margin, FY2025: 8.67%Operating margin, FY2021: 11.34%Operating margin, FY2022: 6.72%Operating margin, FY2023: 7.66%Operating margin, FY2024: 4.29%Operating margin, FY2025: -79.42%Net margin, FY2021: 1.86%Net margin, FY2022: 0.38%Net margin, FY2023: -1.06%Net margin, FY2024: -4.08%Net margin, FY2025: 4.08%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 41.11%. Gross margin FY2022 40.18%. Gross margin FY2023 40.69%. Gross margin FY2024 41.71%. Gross margin FY2025 8.67%. Operating margin FY2021 11.34%. Operating margin FY2022 6.72%. Operating margin FY2023 7.66%. Operating margin FY2024 4.29%. Operating margin FY2025 -79.42%. Net margin FY2021 1.86%. Net margin FY2022 0.38%. Net margin FY2023 -1.06%. Net margin FY2024 -4.08%. Net margin FY2025 4.08%.

Income trends

Revenue

12.49B USD-1.18%

Operating income

−9.92B USD−10.46B USD

Net income

509M USD+1.03B USD
Income trends across reported periods14.89B USD5.87B USD−3.15B USD−12.17B USDRevenue, FY2021: 12.37B USDRevenue, FY2022: 12.21B USDRevenue, FY2023: 12.49B USDRevenue, FY2024: 12.63B USDRevenue, FY2025: 12.49B USDOperating income, FY2021: 1.4B USDOperating income, FY2022: 821M USDOperating income, FY2023: 957M USDOperating income, FY2024: 542M USDOperating income, FY2025: −9.92B USDNet income, FY2021: 230M USDNet income, FY2022: 46M USDNet income, FY2023: −133M USDNet income, FY2024: −516M USDNet income, FY2025: 509M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 12.37B USD. Revenue FY2022 12.21B USD. Revenue FY2023 12.49B USD. Revenue FY2024 12.63B USD. Revenue FY2025 12.49B USD. Operating income FY2021 1.4B USD. Operating income FY2022 821M USD. Operating income FY2023 957M USD. Operating income FY2024 542M USD. Operating income FY2025 −9.92B USD. Net income FY2021 230M USD. Net income FY2022 46M USD. Net income FY2023 −133M USD. Net income FY2024 −516M USD. Net income FY2025 509M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue12.49B USD12.63B USD12.49B USD12.21B USD12.37B USD
Cost of goods sold11.4B USD7.36B USD7.41B USD7.31B USD7.28B USD
Gross profit1.08B USD5.27B USD5.08B USD4.91B USD5.08B USD
Research and development80M USD85M USD108M USD
Selling, general, and administrative299M USD319M USD317M USD308M USD
Operating expenses11B USD4.73B USD4.13B USD4.09B USD3.68B USD
Interest income3M USD2M USD
Interest expense870M USD863M USD832M USD858M USD885M USD
Depreciation and amortization426M USD406M USD425M USD449M USD432M USD
Operating income−9.92B USD542M USD957M USD821M USD1.4B USD
Net income509M USD−516M USD−133M USD46M USD230M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
36%
4 beats, 7 misses, 0 met estimates
Average EPS surprise
-125.96%
11 comparable reports
Latest EPS result
-0.19
Estimate -0.1 · Miss by 83.38%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates1.410.730.06-0.62Q1 '25MissQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 18, 2025: actual -0.42, estimate 0.09, surprise -566.67%, Miss. Q2 2025, reported Apr 23, 2025: actual -0.03, estimate -0.1, surprise +70.00%, Beat. Q3 2025, reported Jul 23, 2025: actual -0.05, estimate 0.05, surprise -200.00%, Miss. Q4 2025, reported Oct 23, 2025: actual 1.27, estimate -0.278, surprise +557.44%, Beat. Q1 2026, reported Feb 18, 2026: actual -0.01, estimate -0.205, surprise +95.11%, Beat. Q2 2026, reported Apr 21, 2026: actual -0.48, estimate -0.113, surprise -323.06%, Miss. Q3 2026, reported Jul 22, 2026: actual -0.19, estimate -0.104, surprise -83.38%, Miss. Q4 2026, reported Oct 22, 2026: actual —, estimate -0.294, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates3.4B3.15B2.91B2.67BQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 18, 2025: actual 3.27B USD, estimate 3.14B USD, surprise +4.06%, Beat. Q2 2025, reported Apr 23, 2025: actual 3.16B USD, estimate 3.05B USD, surprise +3.52%, Beat. Q3 2025, reported Jul 23, 2025: actual 3.13B USD, estimate 3B USD, surprise +4.33%, Beat. Q4 2025, reported Oct 23, 2025: actual 3.09B USD, estimate 2.99B USD, surprise +3.16%, Beat. Q1 2026, reported Feb 18, 2026: actual 3.11B USD, estimate 3.14B USD, surprise -1.00%, Miss. Q2 2026, reported Apr 21, 2026: actual 2.97B USD, estimate 2.95B USD, surprise +0.47%, Beat. Q3 2026, reported Jul 22, 2026: actual 2.83B USD, estimate 2.89B USD, surprise -2.09%, Miss. Q4 2026, reported Oct 22, 2026: actual —, estimate 2.8B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$2.92

2.99% downside
Past 12 months12-month forecastHigh $3.25Average $2.92Low $2.50

Rating distribution

37 ratings
Strong buy00%
Buy822%
Hold2054%
Sell924%
Strong sell00%

Recent analyst actions

8 institutions
JefferiesdowngradeBuyHold
Raymond JamesdowngradeMarket PerformUnderperform

CYH news

Corporate actions

Corporate action history

Dividend

Ex-dividend Dec 13, 2012

$0.25

Special

Record Dec 17, 2012 · Payment Dec 28, 2012

CYH peers

ETFs holding CYH

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research CYH

research.disclaimer